Olav Bergheim

Olav B. Bergheim was the founder of Philips Image Guided Therapy Corp.
(founded 1999), serving as Chairman from 2001 to 2009.
Mr. Bergheim was the founder of Glaukos Corp.
(founded 1998), serving as Director from 2015 to 2016.
Mr. Bergheim was the founder of LoneStar Heart, Inc. (founded 2010), serving as Executive Chairman.
Mr. Bergheim is the founder of Fjord Ventures Inc (founded 2005), serving as Managing Director since 2005.
Mr. Bergheim is the founder of Adagio Medical, Inc. (founded 2011), serving as President, Chief Executive Officer & Director since 2011.
Mr. Bergheim is the founder of Sonendo, Inc. (founded 2006), serving as Director since 2012.
Mr. Bergheim was also the founder of 3F Therapeutics, Inc.,Metronom Health, Inc.,Vessix Vascular, Inc.,Prelude Corp.,Kato Pharmaceuticals, Inc.,Anaxiom Corp.,Otello Medical, Inc.,YAP Therapeutics, Inc.,CardioPolymers, Inc...
Mr. Bergheim was previously Director at Wallace Enterprises, Inc. Mr. Bergheim was Chief Executive Officer & Director at Arges Imaging, Inc. Mr. Bergheim was Chairman & Chief Executive Officer at Adagio Medical Holdings, Inc. in 2024.
Mr. Bergheim was Chairman at Orqis Medical Corp.
Mr. Bergheim was Director at Verus Pharmaceuticals, Inc. Mr. Bergheim was Vice President at Baxter Healthcare Corp.
Mr. Bergheim was Principal at Windy Hill Medical, Inc. Mr. Bergheim was General Partner at Domain Associates LLC from 2004 to 2005.
Mr. Bergheim was President at Baxter Deutschland GmbH.
Mr. Bergheim was Principal at Volcano Therapeutics, Inc. Mr. Bergheim was Principal at Chimeric Therapies, Inc. Mr. Bergheim was President at Cardiovascular Group.
Mr. Bergheim completed undergraduate and graduate studies at the University of Oslo.
Mr. Bergheim earned an MBA degree from the University of Virginia Darden School of Business.